Adeno-associated virus vectors for short hairpin RNA expression (Q36006146)

11 August 2017

Adeno-associated virus vectors for short hairpin RNA expression (English)

1 reference

11 August 2017

0 references

1

Dirk Grimm

1 reference

11 August 2017

Kusum Pandey

2

1 reference

PubMed ID

15644194

11 August 2017

Mark A Kay

series ordinal

3

1 reference

PubMed ID

15644194

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

11 August 2017

Methods in Enzymology

1 reference

11 August 2017

392

1 reference

11 August 2017

381-405

1 reference

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

The cryptic life style of adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Sfold web server for statistical folding and rational design of nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

siRNAs can function as miRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Quantitative analysis of the packaging capacity of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

RNA molecules as anti-cancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Clades of Adeno-associated viruses are widely disseminated in human tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Production methods for gene transfer vectors based on adeno-associated virus serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Local gene knockdown in the brain using viral-mediated RNA interference.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Expression profiling reveals off-target gene regulation by RNAi

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Gene therapy. Seeking the cause of induced leukemias in X-SCID trial

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Control of HIV-1 replication by RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Small interfering RNA production by enzymatic engineering of DNA (SPEED)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Gene therapy death prompts review of adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Inhibition of hepatitis B virus in mice by RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Allele-specific silencing of dominant disease genes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

A resource for large-scale RNA-interference-based screens in mammals.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Inhibition of NF-kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Rational siRNA design for RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Restriction enzyme-generated siRNA (REGS) vectors and libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Enzymatic production of RNAi libraries from cDNAs.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Role of viral vectors and virion shells in cellular gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

Use of adeno-associated viral vector for delivery of small interfering RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2992023-X

7 January 2021

10.1016/S0076-6879(04)92023-X

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15644194